Table 6. Clinical and pathological parameters of CRC patients for the immunohistochemical analysis of FAP protein expression.
| Patients’ clinical and pathological data (n=294) | Average (%) | |
| Age average (range) | 70 (29-93) | |
| Follow-up months (range) | 44 (0-188) | |
| Gender | Male | 203 (69%) |
| Female | 91 (31%) | |
| Histologic subtype | Conventional Adenocarcinoma (AdC) | 231 (79%) |
| Mucinous carcinoma (MuC) | 50 (17%) | |
| Signet ring cell carcinoma (SrcC) | 13 (4%) | |
| Histologic grade (G) | G1 | 37 (13%) |
| G2 | 161 (55%) | |
| G3 | 95 (32%) | |
| Local invasion (pT) | pT1 | 2 (<1%) |
| pT2 | 13 (4%) | |
| pT3 | 178 (61%) | |
| pT4 | 101 (34%) | |
| Affected lymph nodes (N) | N0 | 47 (16%) |
| N1 | 130 (44%) | |
| N2 | 117 (40%) | |
| Distant metastases (M) | M0 | 182 (62%) |
| M1 | 112 (38%) | |
| Stage (TNM system)* | I | 7 (2%) |
| II | 25 (9%) | |
| III | 150 (51%) | |
| IV | 112 (38%) |